A Phase I, Single-centre, Single-blind, Randomised, Placebo-controlled, Single-dose Study to Assess the Safety, Tolerability and Pharmacokinetics After Single Ascending Intravenous Doses of AZD2927 in Healthy Male Subjects.

Trial Profile

A Phase I, Single-centre, Single-blind, Randomised, Placebo-controlled, Single-dose Study to Assess the Safety, Tolerability and Pharmacokinetics After Single Ascending Intravenous Doses of AZD2927 in Healthy Male Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 23 May 2011

At a glance

  • Drugs AZD 2927 (Primary)
  • Indications Arrhythmias
  • Focus Adverse reactions
  • Most Recent Events

    • 23 May 2011 Actual end date (May 2011) added as reported by ClinicalTrials.gov.
    • 23 May 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 15 Feb 2011 Actual initiation date (Jan 2011) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top